JEREMY AUSTIN: Open Payments
NPI 1285293704 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,915 in 209 payments from 26 companies in 2025. Trend: 2023 $577 · 2024 $2,650 · 2025 $3,915
Food & beverage: $3,816Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 66 | $1,011 |
| Janssen Biotech, Inc. | 12 | $463 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $359 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 32 | $325 |
| Aimmune Therapeutics, Inc. | 9 | $208 |
| Ardelyx, Inc. | 9 | $193 |
| Madrigal Pharmaceuticals | 7 | $167 |
| Lilly USA, LLC | 8 | $139 |
| Janssen Scientific Affairs, LLC | 1 | $129 |
| Phathom Pharmaceuticals, Inc. | 7 | $129 |
Products named: TREMFYA, RINVOQ, ENTYVIO, XIFAXAN, CREON, ZENPEP, IBSRELA, REZDIFFRA.
Industry payments across TN — which companies pay providers there.
